TG6050, an oncolytic vaccinia virus encoding interleukin-12 and anti-CTLA-4 antibody, favors tumor regression via profound immune remodeling of the tumor microenvironmentL.Fend, et al.ESMO 2024 Abstract available on the CICON website – Download the abstract and the poster